SEC Filings for Alnylam Pharmaceuticals Inc. (ALNY)

$ 105.82   1.61 (+1.54%) Volume: 501.45k 4:00 PM EDT Apr 3, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
DEFA14AAdditional proxy soliciting materials - definitive503/24/2020
DEF 14AOther definitive proxy statements14303/23/2020
3Initial statement of beneficial ownership of securities203/04/2020
4Statement of changes in beneficial ownership of securities103/04/2020
4Statement of changes in beneficial ownership of securities202/28/2020
4Statement of changes in beneficial ownership of securities202/28/2020
4Statement of changes in beneficial ownership of securities202/28/2020
4Statement of changes in beneficial ownership of securities202/28/2020
4Statement of changes in beneficial ownership of securities202/28/2020
4Statement of changes in beneficial ownership of securities202/28/2020
8-KCurrent report pursuant to Section 13 or 15(d)302/27/2020
4Statement of changes in beneficial ownership of securities102/21/2020
4Statement of changes in beneficial ownership of securities102/13/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans802/13/2020
10-KAnnual report pursuant to Section 13 or 15(d)16802/13/2020
<<
First
<
Prev
123456789101112131415